Browsing by Subject acute toxicity

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 6 to 8 of 8
  • BB.0000744.pdf.jpg
  • Article


  • Authors: Ha Thi Yen, Tran Thanh Tung (2021)

  • The purpose of this research was to evaluate the acute and subchronic toxicities of An Phu Khang capsules through oral administration in experimental animals. The acute toxicity was determined by the method of Litchfield Wilcoxon in Swiss mice. The subchronic toxicity was evaluated by the recommendation of WHO in Wistar rats at these doses of 0.54 g/kg b.w/day (equal to recommended human dose) and 1.62 g/kg b.w/day (3 times as high as recommended human dose) in 4 consecutive weeks. As a result

  • BB.0000750.pdf.jpg
  • Article


  • Authors: Pham Thi Van Anh, Nguyen Van Dam (2021)

  • The purpose of this research is to evaluate the acute and subchronic toxicities of DA DAI TRANG HVD capsules through oral administration in experimental animals. The acute toxicity was determined by the method of Litchfield Wilcoxon in Swiss mice. The subchronic toxicity was evaluated by the recommendation of WHO and OECD in Wistar rats with oral doses of 1.44 g/kg/day (equal to recommended human dose) and 4.32 g/kg/ day (3 times as high as recommended human dose) in 4 consecutive weeks. As a result, DA DAI TRANG HVD capsules at the highest dose used for mice (99.9 g materials/kg) did not express acute toxicity in mice. In term of the subchonic toxicity test, DA DAI TRANG H...

  • BB.0000396.pdf.jpg
  • magazine


  • Authors: Dang Thi Thu Hien; Nguyen Trong Thong; Pham Thuy Phuong (2020)

  • Hamo NK hard capsule is composed of dry extracts formulation of herbal medicine which had shown good properties for effective treatment of dyslipidemia. However, there are no scientific report of its toxicological properties which would guarantee its safe usage as a potent treatment of dyslipidemia. Therefore, the present study was to investigate acute and sub-chronic toxicity of Hamo NK on mice and rats through oral administration. Acute toxicity study was performed in Swiss mice at tolerable ascending doses in mice and followed up to 7 days